A citation-based method for searching scientific literature

Andreas Machens, Kerstin Lorenz, Frank Weber, Henning Dralle. J Clin Endocrinol Metab 2021
Times Cited: 7







List of co-cited articles
13 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.
Henning Dralle, Thomas J Musholt, Jochen Schabram, Thomas Steinmüller, Andreja Frilling, Dietmar Simon, Peter E Goretzki, Bruno Niederle, Christian Scheuba, Thomas Clerici,[...]. Langenbecks Arch Surg 2013
127
42

Omission of lateral lymph node dissection in medullary thyroid cancer without a desmoplastic stromal reaction.
M B Niederle, P Riss, A Selberherr, O Koperek, K Kaserer, B Niederle, C Scheuba. Br J Surg 2021
7
42

Large sporadic thyroid medullary carcinomas: predictive factors for lymph node involvement.
Sébastien Aubert, Amandine Berdelou, Viviane Gnemmi, Hélène Behal, Robert Caiazzo, Michèle D'herbomez, Pascal Pigny, Jean Louis Wemeau, Bruno Carnaille, Florence Renaud,[...]. Virchows Arch 2018
13
28


Biomarker-based risk stratification for previously untreated medullary thyroid cancer.
Andreas Machens, Henning Dralle. J Clin Endocrinol Metab 2010
158
28

Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.
Rossella Elisei, Valeria Bottici, Fabiana Luchetti, Giancarlo Di Coscio, Cristina Romei, Lucia Grasso, Paolo Miccoli, Pietro Iacconi, Fulvio Basolo, Aldo Pinchera,[...]. J Clin Endocrinol Metab 2004
286
28


Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted Sequencing.
Raffaele Ciampi, Cristina Romei, Teresa Ramone, Alessandro Prete, Alessia Tacito, Virginia Cappagli, Valeria Bottici, David Viola, Liborio Torregrossa, Clara Ugolini,[...]. iScience 2019
55
28

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Samuel A Wells, Sylvia L Asa, Henning Dralle, Rossella Elisei, Douglas B Evans, Robert F Gagel, Nancy Lee, Andreas Machens, Jeffrey F Moley, Furio Pacini,[...]. Thyroid 2015
960
28

Utility of serum procalcitonin for screening and risk stratification of medullary thyroid cancer.
Andreas Machens, Kerstin Lorenz, Henning Dralle. J Clin Endocrinol Metab 2014
37
28

Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome.
Bayan Alzumaili, Bin Xu, Philip M Spanheimer, R Michael Tuttle, Eric Sherman, Nora Katabi, Snjezana Dogan, Ian Ganly, Brian R Untch, Ronald A Ghossein. Mod Pathol 2020
15
28

Predicting Outcomes in Sporadic and Hereditary Medullary Thyroid Carcinoma over Two Decades.
Anupam Kotwal, Dana Erickson, Jennifer R Geske, Ian D Hay, M Regina Castro. Thyroid 2021
12
28





The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer.
Nazanene H Esfandiari, David T Hughes, Huiying Yin, Mousumi Banerjee, Megan R Haymart. J Clin Endocrinol Metab 2014
51
14

Nodal disease burden and outcome of medullary thyroid carcinoma.
Lindsey E Moses, Jamie R Oliver, Janine M Rotsides, Qianhui Shao, Kepal N Patel, Luc G T Morris, Babak Givi. Head Neck 2021
5
20


Prognostic and predictive markers in medullary thyroid carcinoma.
Boban M Erovic, Dae Kim, Clarissa Cassol, David P Goldstein, Jonathan C Irish, Sylvia L Asa, Ozgur Mete. Endocr Pathol 2012
19
14

Divergent Metastatic Patterns Between Subtypes of Thyroid Carcinoma Results From the Nationwide Dutch Pathology Registry.
Niek Hugen, Yvette J E Sloot, Romana T Netea-Maier, Carlijn van de Water, Jan W A Smit, Iris D Nagtegaal, Ilse C H van Engen-van Grunsven. J Clin Endocrinol Metab 2020
9
14

A Phase II study of the safety and efficacy of lenvatinib in patients with advanced thyroid cancer.
Shunji Takahashi, Naomi Kiyota, Tomoko Yamazaki, Naoko Chayahara, Kenji Nakano, Lina Inagaki, Kazuhisa Toda, Tomohiro Enokida, Hironobu Minami, Yoshinori Imamura,[...]. Future Oncol 2019
73
14

Efficacy of Selpercatinib in RET-Altered Thyroid Cancers.
Lori J Wirth, Eric Sherman, Bruce Robinson, Benjamin Solomon, Hyunseok Kang, Jochen Lorch, Francis Worden, Marcia Brose, Jyoti Patel, Sophie Leboulleux,[...]. N Engl J Med 2020
192
14

Cabozantinib in progressive medullary thyroid cancer.
Rossella Elisei, Martin J Schlumberger, Stefan P Müller, Patrick Schöffski, Marcia S Brose, Manisha H Shah, Lisa Licitra, Barbara Jarzab, Viktor Medvedev, Michael C Kreissl,[...]. J Clin Oncol 2013
673
14

Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin-stimulation test?
Géraldine Pina, Séverine Dubois, Arnaud Murat, Nicole Berger, Patricia Niccoli, Jean-Louis Peix, Régis Cohen, Claudine Guillausseau, Anne Charrie, Olivier Chabre,[...]. Clin Endocrinol (Oxf) 2013
13
14

Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta-analysis.
Johannes A A Meijer, Saskia le Cessie, Wilbert B van den Hout, Job Kievit, Johannes W Schoones, Johannes A Romijn, Johannes W A Smit. Clin Endocrinol (Oxf) 2010
95
14

Sorafenib in Japanese Patients with Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.
Yasuhiro Ito, Naoyoshi Onoda, Ken-Ichi Ito, Iwao Sugitani, Shunji Takahashi, Iku Yamaguchi, Koki Kabu, Katsuya Tsukada. Thyroid 2017
47
14

A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer.
Martin Schlumberger, Barbara Jarzab, Maria E Cabanillas, Bruce Robinson, Furio Pacini, Douglas W Ball, Judith McCaffrey, Kate Newbold, Roger Allison, Renato G Martins,[...]. Clin Cancer Res 2016
137
14


The value of 18F-DOPA PET/CT in patients with medullary thyroid carcinoma and increased calcitonin values.
Anja T Golubić, Eva Pasini Nemir, Marijan Žuvić, Andrea Mutvar, Sanja Kusačić Kuna, Marija Despot, Tatjana Samardžić, Dražen Huić. Nucl Med Commun 2017
12
14

Calcitonin Stimulation Tests: Rationale, Technical Issues and Side Effects: A Review.
Mara Băetu, Cristina Alexandra Olariu, Gabriel Moldoveanu, Cristina Corneci, Corin Badiu. Horm Metab Res 2021
3
33

Hypervascularity is more frequent in medullary thyroid carcinoma: Compared with papillary thyroid carcinoma.
Xingjian Lai, Meijuan Liu, Yu Xia, Liang Wang, Yalan Bi, Xiaoyi Li, Bo Zhang, Meng Yang, Qing Dai, Yuxin Jiang. Medicine (Baltimore) 2016
9
14

Ultrasonographic characteristics of medullary thyroid carcinoma: a comparison with papillary thyroid carcinoma.
Mei-Juan Liu, Zhong-Feng Liu, Yuan-Yuan Hou, Yan-Ming Men, Yu-Xi Zhang, Ling-Yun Gao, Hao Liu. Oncotarget 2017
17
14

Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules.
Hans Hg Verbeek, Jan Willem B de Groot, Wim J Sluiter, Anneke C Muller Kobold, Edwin R van den Heuvel, John Tm Plukker, Thera P Links. Cochrane Database Syst Rev 2020
16
14

Dynamic risk stratification in medullary thyroid carcinoma: Single institution experiences.
Jung Bum Choi, Seul Gi Lee, Min Jhi Kim, Tae Hyung Kim, Eun Jeong Ban, Cho Rok Lee, Jandee Lee, Sang-Wook Kang, Jong Ju Jeong, Kee-Hyun Nam,[...]. Medicine (Baltimore) 2018
7
14

Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model.
Paul Tappenden, Christopher Carroll, Jean Hamilton, Eva Kaltenthaler, Ruth Wong, Jonathan Wadsley, Laura Moss, Sabapathy Balasubramanian. Health Technol Assess 2019
18
14

Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment.
L Fugazzola, M Di Stefano, S Censi, A Repaci, C Colombo, F Grimaldi, F Magri, U Pagotto, M Iacobone, L Persani,[...]. J Endocrinol Invest 2021
12
14

Ultrasound features and risk stratification systems to identify medullary thyroid carcinoma.
Antonio Matrone, Carla Gambale, Margherita Biagini, Alessandro Prete, Paolo Vitti, Rossella Elisei. Eur J Endocrinol 2021
7
14

Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
Martin B Niederle, Christian Scheuba, Philipp Riss, Andreas Selberherr, Oskar Koperek, Bruno Niederle. Thyroid 2020
23
14


Limitations of preoperative cytology for medullary thyroid cancer: Proposal for improved preoperative diagnosis for optimal initial medullary thyroid carcinoma specific surgery.
Alan D Workman, Selen Soylu, Dipti Kamani, Anahita Nourmahnad, Natalia Kyriazidis, Ryan Saade, Yin Ren, Lori Wirth, William C Faquin, Ayşe M Onenerk,[...]. Head Neck 2021
7
14


Advances in the Management of Medullary Thyroid Carcinoma: Focus on Peptide Receptor Radionuclide Therapy.
Erika Grossrubatscher, Giuseppe Fanciulli, Luca Pes, Franz Sesti, Carlotta Dolci, Federica de Cicco, Annamaria Colao, Antongiulio Faggiano, Nike Group. J Clin Med 2020
12
14

Ca19.9 Positivity and Doubling Time Are Prognostic Factors of Mortality in Patients with Advanced Medullary Thyroid Cancer with No Evidence of Structural Disease Progression According to Response Evaluation Criteria in Solid Tumors.
Loredana Lorusso, Cristina Romei, Paolo Piaggi, Chiara Fustini, Eleonora Molinaro, Laura Agate, Valeria Bottici, David Viola, Giovanni Pellegrini, Rossella Elisei. Thyroid 2021
6
16

Vandetanib Tumor Shrinkage in Metastatic Medullary Thyroid Cancer Allowing Surgical Resection of the Primary Site: A Case Report.
Thomas D Milner, Milind Ronghe, Mohamad G Shaikh, Fiona B MacGregor, Nicholas Reed. J Pediatr Hematol Oncol 2019
6
16

Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA Trial.
Michael C Kreissl, Lars Bastholt, Rossella Elisei, Robert Haddad, Ole Hauch, Barbara Jarząb, Bruce Robinson, Raffaella Colzani, Meredith Foster, Richard Weiss,[...]. J Clin Oncol 2020
17
14

Different outcomes in sporadic versus familial medullary thyroid cancer.
Katerina Saltiki, George Simeakis, Elli Anagnostou, Evangelia Zapanti, Eleni Anastasiou, Maria Alevizaki. Head Neck 2019
12
14

Procalcitonin: A New Biomarker for Medullary Thyroid Cancer? A Systematic Review.
Apostolos K A Karagiannis, Constantine Girio-Fragkoulakis, Theodora Nakouti. Anticancer Res 2016
13
14

State-of-the-Art Strategies for Targeting RET-Dependent Cancers.
Vivek Subbiah, Dong Yang, Vamsidhar Velcheti, Alexander Drilon, Funda Meric-Bernstam. J Clin Oncol 2020
81
14

Neoadjuvant selpercatinib for advanced medullary thyroid cancer.
Yelda Jozaghi, Mark Zafereo, Michelle D Williams, Maria K Gule-Monroe, Jennifer Wang, Elizabeth G Grubbs, Ara Vaporciyan, Mimi I Hu, Naifa Busaidy, Ramona Dadu,[...]. Head Neck 2021
19
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.